Logo image of 1PFE.MI

PFIZER INC (1PFE.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1PFE - US7170811035 - Common Stock

21.83 EUR
+0.03 (+0.14%)
Last: 1/21/2026, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, 1PFE scores 4 out of 10 in our fundamental rating. 1PFE was compared to 54 industry peers in the Pharmaceuticals industry. While 1PFE is still in line with the averages on profitability rating, there are concerns on its financial health. 1PFE is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year 1PFE was profitable.
  • 1PFE had a positive operating cash flow in the past year.
  • 1PFE had positive earnings in each of the past 5 years.
  • In the past 5 years 1PFE always reported a positive cash flow from operatings.
1PFE.MI Yearly Net Income VS EBIT VS OCF VS FCF1PFE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

  • 1PFE has a Return On Assets of 4.71%. This is comparable to the rest of the industry: 1PFE outperforms 44.44% of its industry peers.
  • With a Return On Equity value of 10.59%, 1PFE perfoms like the industry average, outperforming 51.85% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 7.96%, 1PFE is in line with its industry, outperforming 51.85% of the companies in the same industry.
  • 1PFE had an Average Return On Invested Capital over the past 3 years of 10.72%. This is below the industry average of 13.93%.
Industry RankSector Rank
ROA 4.71%
ROE 10.59%
ROIC 7.96%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.72%
ROIC(5y)10.58%
1PFE.MI Yearly ROA, ROE, ROIC1PFE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • 1PFE has a better Profit Margin (15.65%) than 64.81% of its industry peers.
  • 1PFE's Profit Margin has declined in the last couple of years.
  • 1PFE's Operating Margin of 29.12% is fine compared to the rest of the industry. 1PFE outperforms 75.93% of its industry peers.
  • 1PFE's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 74.95%, 1PFE is doing good in the industry, outperforming 74.07% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1PFE has declined.
Industry RankSector Rank
OM 29.12%
PM (TTM) 15.65%
GM 74.95%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
1PFE.MI Yearly Profit, Operating, Gross Margins1PFE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

  • 1PFE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for 1PFE has been increased compared to 1 year ago.
  • Compared to 5 years ago, 1PFE has more shares outstanding
  • Compared to 1 year ago, 1PFE has an improved debt to assets ratio.
1PFE.MI Yearly Shares Outstanding1PFE.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
1PFE.MI Yearly Total Debt VS Total Assets1PFE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

  • An Altman-Z score of 2.22 indicates that 1PFE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • 1PFE has a Altman-Z score of 2.22. This is comparable to the rest of the industry: 1PFE outperforms 40.74% of its industry peers.
  • The Debt to FCF ratio of 1PFE is 5.95, which is a neutral value as it means it would take 1PFE, 5.95 years of fcf income to pay off all of its debts.
  • 1PFE has a Debt to FCF ratio (5.95) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.62 indicates that 1PFE is somewhat dependend on debt financing.
  • The Debt to Equity ratio of 1PFE (0.62) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.95
Altman-Z 2.22
ROIC/WACC0.91
WACC8.71%
1PFE.MI Yearly LT Debt VS Equity VS FCF1PFE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

  • 1PFE has a Current Ratio of 1.28. This is a normal value and indicates that 1PFE is financially healthy and should not expect problems in meeting its short term obligations.
  • 1PFE has a Current ratio (1.28) which is in line with its industry peers.
  • 1PFE has a Quick Ratio of 1.28. This is a bad value and indicates that 1PFE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.97, 1PFE is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.97
1PFE.MI Yearly Current Assets VS Current Liabilites1PFE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.03% over the past year.
  • The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
  • 1PFE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.90%.
  • Measured over the past years, 1PFE shows a quite strong growth in Revenue. The Revenue has been growing by 9.10% on average per year.
EPS 1Y (TTM)24.03%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%-17.92%
Revenue 1Y (TTM)3.9%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-5.92%

3.2 Future

  • Based on estimates for the next years, 1PFE will show a decrease in Earnings Per Share. The EPS will decrease by -5.87% on average per year.
  • 1PFE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.45% yearly.
EPS Next Y1.34%
EPS Next 2Y-1.16%
EPS Next 3Y-2.35%
EPS Next 5Y-5.87%
Revenue Next Year-1.45%
Revenue Next 2Y-1.57%
Revenue Next 3Y-2.05%
Revenue Next 5Y-3.45%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1PFE.MI Yearly Revenue VS Estimates1PFE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
1PFE.MI Yearly EPS VS Estimates1PFE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.00, the valuation of 1PFE can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1PFE indicates a rather cheap valuation: 1PFE is cheaper than 96.30% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.32. 1PFE is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 8.44 indicates a reasonable valuation of 1PFE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1PFE indicates a rather cheap valuation: 1PFE is cheaper than 96.30% of the companies listed in the same industry.
  • 1PFE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.30.
Industry RankSector Rank
PE 8
Fwd PE 8.44
1PFE.MI Price Earnings VS Forward Price Earnings1PFE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1PFE is valued cheaply inside the industry as 87.04% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, 1PFE is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.04
EV/EBITDA 7.16
1PFE.MI Per share data1PFE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1PFE does not grow enough to justify the current Price/Earnings ratio.
  • A cheap valuation may be justified as 1PFE's earnings are expected to decrease with -2.35% in the coming years.
PEG (NY)5.98
PEG (5Y)7.53
EPS Next 2Y-1.16%
EPS Next 3Y-2.35%

6

5. Dividend

5.1 Amount

  • 1PFE has a Yearly Dividend Yield of 6.64%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.59, 1PFE pays a better dividend. On top of this 1PFE pays more dividend than 98.15% of the companies listed in the same industry.
  • 1PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.86.
Industry RankSector Rank
Dividend Yield 6.64%

5.2 History

  • The dividend of 1PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1PFE pays out 98.76% of its income as dividend. This is not a sustainable payout ratio.
  • 1PFE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP98.76%
EPS Next 2Y-1.16%
EPS Next 3Y-2.35%
1PFE.MI Yearly Income VS Free CF VS Dividend1PFE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
1PFE.MI Dividend Payout.1PFE.MI Dividend Payout, showing the Payout Ratio.1PFE.MI Dividend Payout.PayoutRetained Earnings

PFIZER INC

BIT:1PFE (1/21/2026, 7:00:00 PM)

21.83

+0.03 (+0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-04
Earnings (Next)02-03
Inst Owners67.61%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap124.12B
Revenue(TTM)62.79B
Net Income(TTM)9.83B
Analysts70.91
Price Target25.38 (16.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.64%
Yearly Dividend1.45
Dividend Growth(5Y)3.3%
DP98.76%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.46%
Min EPS beat(2)32.91%
Max EPS beat(2)36.01%
EPS beat(4)4
Avg EPS beat(4)34.72%
Min EPS beat(4)32.52%
Max EPS beat(4)37.45%
EPS beat(8)8
Avg EPS beat(8)54.91%
EPS beat(12)12
Avg EPS beat(12)44.86%
EPS beat(16)16
Avg EPS beat(16)38.4%
Revenue beat(2)1
Avg Revenue beat(2)3.22%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)6.96%
Revenue beat(4)2
Avg Revenue beat(4)1.35%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)6.96%
Revenue beat(8)5
Avg Revenue beat(8)3.39%
Revenue beat(12)7
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)3.12%
PT rev (1m)0.22%
PT rev (3m)-0.34%
EPS NQ rev (1m)-3.25%
EPS NQ rev (3m)-20.04%
EPS NY rev (1m)-0.67%
EPS NY rev (3m)0.67%
Revenue NQ rev (1m)-2.37%
Revenue NQ rev (3m)-4.09%
Revenue NY rev (1m)-0.56%
Revenue NY rev (3m)-1.73%
Valuation
Industry RankSector Rank
PE 8
Fwd PE 8.44
P/S 2.32
P/FCF 14.04
P/OCF 11.14
P/B 1.57
P/tB N/A
EV/EBITDA 7.16
EPS(TTM)2.73
EY12.51%
EPS(NY)2.59
Fwd EY11.85%
FCF(TTM)1.55
FCFY7.12%
OCF(TTM)1.96
OCFY8.98%
SpS9.41
BVpS13.9
TBVpS-4.14
PEG (NY)5.98
PEG (5Y)7.53
Graham Number29.22
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 10.59%
ROCE 10.62%
ROIC 7.96%
ROICexc 8.72%
ROICexgc 37.28%
OM 29.12%
PM (TTM) 15.65%
GM 74.95%
FCFM 16.53%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.72%
ROIC(5y)10.58%
ROICexc(3y)12.29%
ROICexc(5y)12.49%
ROICexgc(3y)49.08%
ROICexgc(5y)45.53%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexgc growth 3Y-10.89%
ROICexgc growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score6
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.95
Debt/EBITDA 2.3
Cap/Depr 40.34%
Cap/Sales 4.3%
Interest Coverage 5.8
Cash Conversion 52.35%
Profit Quality 105.58%
Current Ratio 1.28
Quick Ratio 0.97
Altman-Z 2.22
F-Score6
WACC8.71%
ROIC/WACC0.91
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)24.03%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%-17.92%
EPS Next Y1.34%
EPS Next 2Y-1.16%
EPS Next 3Y-2.35%
EPS Next 5Y-5.87%
Revenue 1Y (TTM)3.9%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-5.92%
Revenue Next Year-1.45%
Revenue Next 2Y-1.57%
Revenue Next 3Y-2.05%
Revenue Next 5Y-3.45%
EBIT growth 1Y-5.75%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year16.58%
EBIT Next 3Y4.11%
EBIT Next 5Y-0.68%
FCF growth 1Y26.86%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y8.59%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%

PFIZER INC / 1PFE.MI FAQ

What is the ChartMill fundamental rating of PFIZER INC (1PFE.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1PFE.MI.


What is the valuation status of PFIZER INC (1PFE.MI) stock?

ChartMill assigns a valuation rating of 7 / 10 to PFIZER INC (1PFE.MI). This can be considered as Undervalued.


What is the profitability of 1PFE stock?

PFIZER INC (1PFE.MI) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for 1PFE stock?

The Earnings per Share (EPS) of PFIZER INC (1PFE.MI) is expected to grow by 1.34% in the next year.


How sustainable is the dividend of PFIZER INC (1PFE.MI) stock?

The dividend rating of PFIZER INC (1PFE.MI) is 6 / 10 and the dividend payout ratio is 98.76%.